Quest Diagnostics (DGX) reports a potential patient data breach in its Quanum LSM system on 2026-10-22. Investors should assess data-security and legal risks.
Quest Diagnostics (DGX) executive Catherine Doherty will retire July 2027; role transition in 2026. Key investor takeaways on strategy, operations and risks.